Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder
Author:
Funder
SAGE Therapeutics Inc
Publisher
Elsevier BV
Subject
Psychiatry and Mental health,Clinical Psychology
Reference66 articles.
1. Neurosteroids promote phosphorylation and membrane insertion of extrasynaptic GABAA receptors;Abramian;Proc Natl Acad Sci U S A,2014
2. Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator;Althaus;Neuropharmacology,2020
3. Diagnostic and statistical manual of mental disorders,2013
4. Antidepressants versus placebo for depression in primary care;Arroll;Cochrane Database of Systematic Reviews,2009
5. Modifiable risk factors predicting major depressive disorder at four year follow-up: a decision tree approach;Batterham;BMC Psychiatry,2009
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis;Expert Opinion on Pharmacotherapy;2024-01-02
2. A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model;RSC Pharmaceutics;2024
3. Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder;Journal of Affective Disorders;2023-11
4. Neurosteroid influence on affective tone;Neuroscience & Biobehavioral Reviews;2023-09
5. Neurosteroids: mechanistic considerations and clinical prospects;Neuropsychopharmacology;2023-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3